Nabilone controlled release (AOP Orphan Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNabilone controlled release (AOP Orphan Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAop Orphan PharmaceuticalsMedical University Of Innsbruck
China Registration ClassN/A

Develop Information

Active CompaniesAop Orphan PharmaceuticalsMedical University Of Innsbruck
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG